🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(5513)
All (5513)
Buys (549)
Sells (4964)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
5
Price
$781.48
Total Value
$3.91K
Shares Held After
17,812
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
1
Price
$780.09
Total Value
$780.09
Shares Held After
17,817
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
5
Price
$779.41
Total Value
$3.90K
Shares Held After
17,818
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
12
Price
$778.53
Total Value
$9.34K
Shares Held After
17,823
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
57
Price
$777.56
Total Value
$44.32K
Shares Held After
17,835
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
10
Price
$776.59
Total Value
$7.77K
Shares Held After
17,892
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
RYAN ARTHUR F
— Director
Feb 9, 2026
Sale
Shares
1
Price
$775.63
Total Value
$775.63
Shares Held After
17,902
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
53
Price
$785.72
Total Value
$41.64K
Shares Held After
4,272
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
1
Price
$784.66
Total Value
$784.66
Shares Held After
4,325
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
144
Price
$783.23
Total Value
$112.79K
Shares Held After
4,326
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
37
Price
$782.67
Total Value
$28.96K
Shares Held After
4,470
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
26
Price
$781.37
Total Value
$20.32K
Shares Held After
4,507
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
75
Price
$780.06
Total Value
$58.50K
Shares Held After
4,533
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
205
Price
$779.56
Total Value
$159.81K
Shares Held After
4,608
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
563
Price
$778.35
Total Value
$438.21K
Shares Held After
4,813
% of Holdings
10.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
391
Price
$777.51
Total Value
$304.01K
Shares Held After
5,376
% of Holdings
6.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
521
Price
$776.43
Total Value
$404.52K
Shares Held After
5,767
% of Holdings
8.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REGENERON PHARMACEUTICALS, INC.
(REGN)
Pitofsky Jason
— SVP Controller
Feb 9, 2026
Sale
Shares
20
Price
$775.95
Total Value
$15.52K
Shares Held After
6,288
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Gottlieb Scott
— Director
Feb 9, 2026
Purchase
Shares
200
Price
$117.81
Total Value
$23.56K
Shares Held After
12,723
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SpyGlass Pharma, Inc. Common Stock
(SGP)
Khan Bilal Arshad
— Director
Feb 9, 2026
Purchase
Shares
115,000
Price
$16.00
Total Value
$1.84M
Shares Held After
251,427
% of Holdings
45.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SpyGlass Pharma, Inc. Common Stock
(SGP)
Khan Bilal Arshad
— Director
Feb 9, 2026
Purchase
Shares
20,000
Price
$16.00
Total Value
$320.00K
Shares Held After
25,450
% of Holdings
78.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SpyGlass Pharma, Inc. Common Stock
(SGP)
Pardo Geoffrey B
— Director
Feb 9, 2026
Purchase
Shares
312,500
Price
$16.00
Total Value
$5.00M
Shares Held After
2,187,513
% of Holdings
14.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Entera Bio Ltd.
(ENTX)
Ellis Sean
— Director
Feb 9, 2026
Purchase
Shares
18,000
Price
$1.24
Total Value
$22.32K
Shares Held After
178,098
% of Holdings
10.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Entera Bio Ltd.
(ENTX)
Rubin Steven D
— Director
Feb 9, 2026
Purchase
Shares
10,000
Price
$1.20
Total Value
$12.00K
Shares Held After
10,000
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zentalis Pharmaceuticals, Inc.
(ZNTL)
EASTLAND JULIA MARIE
— Director
Feb 9, 2026
Sale
Shares
889
Price
$2.39
Total Value
$2.13K
Shares Held After
79,133
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zentalis Pharmaceuticals, Inc.
(ZNTL)
Bruns Ingmar
— Chief Medical Officer
Feb 9, 2026
Sale
Shares
335
Price
$2.39
Total Value
$801.62
Shares Held After
33,332
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zentalis Pharmaceuticals, Inc.
(ZNTL)
Vultaggio Vincent
— PAO and PFO
Feb 9, 2026
Sale
Shares
3,379
Price
$2.39
Total Value
$8.09K
Shares Held After
153,400
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
Spignesi Robert G. Jr.
— Director
Feb 9, 2026
Sale
Shares
12,840
Price
$3.78
Total Value
$48.57K
Shares Held After
962,097
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
WIRTJES SEAN M
— CHIEF FINANCIAL OFFICER
Feb 9, 2026
Sale
Shares
6,027
Price
$3.78
Total Value
$22.80K
Shares Held After
483,928
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RAPID MICRO BIOSYSTEMS, INC.
(RPID)
Wilson John J. Addington
— CHIEF OPERATING OFFICER
Feb 9, 2026
Sale
Shares
4,610
Price
$3.78
Total Value
$17.44K
Shares Held After
257,768
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
BENKOWITZ MICHAEL
— PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
7,875
Price
$474.65
Total Value
$3.74M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
BENKOWITZ MICHAEL
— PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
14,625
Price
$474.65
Total Value
$6.94M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ACADIA PHARMACEUTICALS INC
(ACAD)
Rhodes Jennifer J
— EVP, CHIEF LEGAL OFFICER, SEC
Feb 9, 2026
Sale
Shares
6,950
Price
$23.38
Total Value
$162.49K
Shares Held After
7,609
% of Holdings
47.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SpyGlass Pharma, Inc. Common Stock
(SGP)
Vensana Capital I GP, LLC
— 10% Owner
Feb 9, 2026
Purchase
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SpyGlass Pharma, Inc. Common Stock
(SGP)
Nielsen Kirk G.
— Director
Feb 9, 2026
Purchase
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
McFarlane Neil F.
— Director
Feb 9, 2026
Sale
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Biogen Inc.
(BIIB)
Singhal Priya
— Head of Development
Feb 9, 2026
Sale
Shares
2,660
Price
$199.83
Total Value
$531.55K
Shares Held After
8,043
% of Holdings
24.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LABCORP HOLDINGS INC.
(LH)
Meltzer Jonathan C
— EVP, Operations
Feb 9, 2026
Sale
Shares
88
Price
$275.53
Total Value
$24.25K
Shares Held After
2,869
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RESMED INC
(RMD)
Farrell Michael J.
— Director
Feb 9, 2026
Sale
Shares
4,991
Price
$273.78
Total Value
$1.37M
Shares Held After
466,223
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Syndax Pharmaceuticals, Inc.
(SNDX)
Metzger Michael A
— Director
Feb 9, 2026
Sale
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Syndax Pharmaceuticals, Inc.
(SNDX)
Goldan Keith A.
— Chief Financial Officer
Feb 9, 2026
Sale
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Ring Christine
— Chief Legal Officer
Feb 9, 2026
Sale
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ENSIGN GROUP, INC
(ENSG)
Parkinson Mark Vincent
— Director
Feb 9, 2026
Sale
Shares
100
Price
$198.00
Total Value
$19.80K
Shares Held After
2,900
% of Holdings
3.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ENSIGN GROUP, INC
(ENSG)
Blouin Ann Scott
— Director
Feb 9, 2026
Sale
Shares
375
Price
$198.00
Total Value
$74.25K
Shares Held After
22,852
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Merck & Co., Inc.
(MRK)
Zachary Jennifer
— EVP, General Counsel
Feb 9, 2026
Sale
Shares
38,835
Price
$119.15
Total Value
$4.63M
Shares Held After
68,916
% of Holdings
36.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Merck & Co., Inc.
(MRK)
Zachary Jennifer
— EVP, General Counsel
Feb 9, 2026
Sale
Shares
56,792
Price
$119.15
Total Value
$6.77M
Shares Held After
68,916
% of Holdings
45.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Merck & Co., Inc.
(MRK)
Zachary Jennifer
— EVP, General Counsel
Feb 9, 2026
Sale
Shares
25,946
Price
$119.15
Total Value
$3.09M
Shares Held After
68,916
% of Holdings
27.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Merck & Co., Inc.
(MRK)
Guindo Chirfi
— Chief Marketing Officer
Feb 9, 2026
Sale
Shares
10,000
Price
$118.41
Total Value
$1.18M
Shares Held After
70,615
% of Holdings
12.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
EKSO BIONICS HOLDINGS, INC.
(EKSO)
ASHER DANIEL
— 10% Owner
Feb 6, 2026
Purchase
Shares
194
Price
$9.86
Total Value
$1.91K
Shares Held After
156,957
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zentalis Pharmaceuticals, Inc.
(ZNTL)
EASTLAND JULIA MARIE
— Director
Feb 6, 2026
Sale
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 3601–3650 of 5513 transactions (page 73 of 111)
Version: v26.3.33